Thu, Apr 24, 2014, 3:29 AM EDT - U.S. Markets open in 6 hrs 1 mins

Recent

% | $
Quotes you view appear here for quick access.

Thermo Fisher Scientific, Inc. Message Board

  • stengaard_dk stengaard_dk Jun 17, 2012 7:07 PM Flag

    Phadia lost the case friday

    Friday saw a verdict in the long running courtcase (6 years) between swedish Phadia and danish Bioporto.

    Phadia (now owned by Thermo Fischer) had a patent on NGAL - supposedly covering all human diseases. The patent has never been used actively by Phadia, but the rights to pursue the Patent has been given to Abbott - who wanted to use it as a legal base for their Architect heterogenous NGAL Test.

    friday - Phadia/
    Abbott lost the case - which ultimately will give BioPorto unhindered market access (and close the door for Abbott) a market that is potentially as large as the heartmarker Toponin..

    read about the verdict - and its implications:

    http://medicoinvestor.com/ngal-bioporto-and-phadia-i-medwatch-dk/

 
TMO
119.39-0.96(-0.80%)Apr 23 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.